What is the main purpose of the amendment to Amgen's ESPP?

The main purpose of the amendment is to provide employees participating in the ESPP with the option to receive any remaining funds (Residuals) in their account that are insufficient to purchase a full share of Amgen common stock, rather than having those funds automatically applied to the next offering period.

How does this amendment benefit Amgen employees?

This amendment offers employees more immediate access to their money. They can receive smaller cash amounts as soon as administratively feasible after an exercise date, rather than waiting for the next purchase period to potentially utilize those funds.

Does this amendment have a significant financial impact on Amgen Inc.?

This amendment primarily relates to the mechanics of an employee benefit plan. It is unlikely to have a significant direct financial impact on Amgen Inc.'s overall financial performance or reported earnings, as it deals with the distribution of employee contributions and is not a new revenue-generating initiative or a change in the company's core business operations.

What is a 'Residual' in the context of the ESPP?

A 'Residual' refers to any amount of money remaining in an employee's ESPP account that is less than the amount required to purchase one whole share of Amgen Inc. common stock at the time of an offering's exercise date.

AMGN 8-K: Material Agreements

Summary

Amgen Inc. (AMGN) filed an 8-K on July 13, 2005, reporting an amendment to its Employee Stock Purchase Plan (ESPP). The key change, effective July 12, 2005, allows for the distribution of "Residuals" – amounts less than what's needed to purchase a full share of Amgen common stock – to participants as soon as administratively practicable after the exercise date. Previously, these residual amounts were automatically rolled over into the next offering unless a participant opted out or was ineligible. This amendment aims to provide participants with greater flexibility and immediate access to their accumulated funds within the ESPP. For investors, this is a largely administrative change related to employee compensation and benefit plans. It does not appear to have a direct material impact on the company's financial performance or strategic direction, but rather enhances the value proposition of the ESPP for its employees.

Key Highlights

1Amgen Inc. amended its Amended and Restated Employee Stock Purchase Plan (ESPP).
2The amendment is effective July 12, 2005.
3The primary change allows for the distribution of 'Residuals' (funds less than a full share purchase) to participants.
4Distribution of Residuals will occur as soon as administratively practicable after the exercise date.
5This differs from the previous policy where Residuals were automatically applied to the next offering.
6The amendment was approved by the Compensation and Management Development Committee of the Board of Directors.
7The full text of the amendment is filed as Exhibit 10.1 to the 8-K.

AMGEN INC 8-K Report, Material Agreement (Jul 14, 2005)

Summary

Key Highlights

Frequently Asked Questions